New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
15:28 EDTNSPHNanosphere receives FDA clearance for C. difficile test
Nanosphere announced the FDA granted 510(k) clearance permitting marketing of its C.difficile test on the automated sample-to-result Verigene System. The C. difficile test expands Nanosphere's infectious disease test capabilities. C. difficile infection is a cause of diarrhea that can lead to colitis, other serious intestinal conditions and death. In less than two hours, the C. difficile test detects the toxin A and B gene sequences of C. difficile and identifies the PCR ribotype 027 strain which is associated with increased severity of disease and used for infection control. Early and accurate diagnosis of C. difficile infections is critical in both the proper treatment of infected patients and subsequent implementation of isolation and containment procedures to prevent further spread of the infection.
News For NSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
17:06 EDTNSPHNanosphere to ask holders to approve reverse stock split
Nanosphere announced that it will conduct a special meeting of stockholders on Tuesday, April 7. At the special meeting, stockholders will be asked to approve amendments to Nanosphere's charter to increase the authorized shares of its common stock from 150M to 250M shares, and to effect a reverse stock split of its issued and outstanding common stock with a ratio in a range of between 15-to-1 and 25-to-1 for the purpose of regaining compliance with the $1 minimum bid price requirement of the NASDAQ Capital Market. The board of directors will determine the exact ratio of the reverse stock split within such range, assuming stockholders approve the reverse stock split at the special meeting. In connection with the special meeting of stockholders, Nanosphere has filed with the SEC a definitive proxy statement describing the charter amendments that will be mailed to stockholders on or about Friday, March 6 to solicit proxies in support of the charter amendments. Nanosphere has engaged MacKenzie Partners to serve as its proxy solicitor for the special meeting of stockholder.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use